Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool January 20, 2009 Rich Duprey	Johnson Controls Is Outta Control But it's not its fault that the auto sector crashed and construction demand crumpled.
Chemistry World October 23, 2012 Andrew Turley	Bankruptcy for US Li ion battery maker US lithium iron phosphate battery maker A123 Systems has filed for bankruptcy. Meanwhile, it has arranged to sell its automotive batteries business to technology giant Johnson Controls.
The Motley Fool January 19, 2007 Ryan Fuhrmann	A New Vehicle for Johnson Controls The company is moving out of the declining automotive business, bringing some uncertainty. Investors, take note.
The Motley Fool August 26, 2005 Stephen D. Simpson	Cool Heads at Johnson Controls An auto parts company buying an HVAC company? It might make sense. While I wouldn't recommend buying York, Johnson Controls might be worth at least a further look for some investors.
The Motley Fool July 28, 2010 Mark Boslet	Lithium Battery Oversupply Debate Rages Makers of lithium-ion batteries are rapidly expanding their factories in anticipation of a ballooning market for electric cars. The trouble is, none of them can be sure what the demand will be.
The Motley Fool April 27, 2010 Rich Smith	This Just In: Upgrades and Downgrades Johnson Controls announced a "beat and raise" quarter, outstripping analyst profit estimates by $0.04 per share and promising to repeat the feat later this year. The news convinced Wall Street's R.W. Baird to up its rating on the stock to "outperform."
Bank Technology News April 2010 Oksana Poltavets	Johnson Financial Saves Green by Going Green Constructing the bank's new home required thousands of square yards of rubble to be carted away. Instead of moving the junk to a landfill, where it would degrade for generations, Johnson Financial hauled the majority of the debris away for recycling.
The Motley Fool June 16, 2011 Jordan DiPietro	Should You Retire With Johnson Controls? Johnson Controls' valuation, dividends, growth and low volatility can tell us if it has the traits of a good retirement stock.
Inc. July 2009	A Business Guide to Energy Conservation How to use less energy and lower your business's utility bills.
The Motley Fool June 28, 2011 Eric Bleeker	Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales?
National Defense October 2009 Jean & Erwin	On The Road to More Fuel-Efficient Vehicles A123Systems, a lithium ion battery producer, has teamed with the Energy Department's Oak Ridge National Laboratory to develop fuel-efficient vehicle technology. Funding for the joint project is being provided under the Recovery Act.
IndustryWeek December 16, 2005	A Rewarding Journey Sustainable manufacturing is a journey. Each step makes life better for our business and for the communities we call home.
The Motley Fool January 17, 2007 Rich Smith	Foolish Forecast: Can Johnson Control Its Numbers? The auto parts maker is set to report its fiscal first-quarter 2007 numbers shortly. Investors, do you want to know what Wall Street expects to see? Do you want to know what really matters?
The Motley Fool December 1, 2010 Seth Jayson	Here's Why Johnson Controls Is Earning so Much for You Here's the current margin snapshot for Johnson Controls and some of its sector and industry peers and direct competitors.
The Motley Fool December 1, 2010 Brian Orelli	We're Still Buying. Probably. Despite manufacturing problems, Johnson &Johnson continues with its purchase of Crucell.
The Motley Fool June 25, 2010 Brian Orelli	The Joys of Being Large and Diversified Johnson & Johnson's plant closure is a rounding error.
The Motley Fool January 19, 2012 Seth Jayson	Johnson Controls Meets on the Top Line, Misses Where It Counts For the quarter ended Dec. 31, Johnson Controls met expectations on revenues and missed on earnings per share.
HBS Working Knowledge May 9, 2005 Liker & Choi	What Westerners Don't Know About Keiretsu Many U.S. executives believe that the keiretsu system -- leveraging shared business interests among a network of suppliers -- is inefficient and inflexible. So what do Toyota and Honda understand that they don't?
The Motley Fool July 31, 2007 Nathan Parmelee	Break Out the Band-Aids at J&J Johnson & Johnson is making some deep cuts to change its cost structure. Shareholders haven't had much to cheer about lately here, but the potential benefits from this move could help cure some of the current softness in the business.
The Motley Fool July 14, 2008 Brian Orelli	Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut?
The Motley Fool April 29, 2011 David Williamson	Johnson & Johnson's Traumatic Purchase Johnson & Johnson agrees to purchase trauma and spine specialist Synthes.
CIO October 12, 2009 Kristin Burnham	How Le Bonheur Children's Medical Center Rebuilt its Facility Engaging stakeholders in a board game helped prioritize high-tech amenities.
The Motley Fool April 28, 2009 David Lee Smith	Grey Skies to Clear Up at 3M? Stephen Roell, 3M's chief executive, displays some new optimism about the second half of this year.
The Motley Fool May 28, 2010 Brian Orelli	How Much Is This Going to Cost J&J? Investors need an answer from Johnson & Johnson about low-quality drugs that were recalled. Is the problem systemic, and if so, how much will it cost the company to fix the problem?
The Motley Fool August 24, 2010 Brian Orelli	One Day, the J&J Recalls Will End Just not today. Johnson & Johnson's consumer health segment gets more than half of its sales from outside the U.S., so tainting its image outside the U.S. could be costly as well.
The Motley Fool November 26, 2010 Brian Orelli	Get It Together, Johnson & Johnson Another day, another recall.
The Motley Fool May 26, 2010 Brian Orelli	Is Johnson & Johnson a Buy? Let's see what it says to Congress first on safety issues.
PC Magazine April 4, 2008 Frank Washburn	Charging Into the Future Researchers are upgrading lithium ion and green-alternative batteries for increasingly power-hungry mobile devices.
The Motley Fool January 15, 2010 Brian Orelli	The Odor Lingers at Johnson & Johnson The company has to recall products because of a smelly problem.
The Motley Fool October 12, 2004 Alyce Lomax	Take It Away, J&J Should investors sweat a coming slowdown in growth for pharmaceutical and consumer products giant Johnson & Johnson?
The Motley Fool August 27, 2010 Brian Orelli	A Recall a Week, That's All We Ask For Johnson & Johnson, apparently that's too much.
The Motley Fool April 18, 2007 Ryan Fuhrmann	Healthy Prognosis at Johnson & Johnson The long-term prognosis for JNJ remains healthy. Investors, take note.
The Motley Fool September 29, 2011 Brian Orelli	Joint-Venture Acid Reflux Merck ditches its joint venture with Johnson & Johnson.
The Motley Fool February 28, 2011 Brian Orelli	Johnson & Johnson Parties Like It's 1982 The big pharma announced that it was recalling 667,632 packages of Sudafed tablets because the instructions contained a typo.
CRM February 2011 Koa Beck	Information Overload Unilever's unsightly knowledge base was costing the company money, customer satisfaction, and time -- until it turned to Astute Solutions
The Motley Fool October 19, 2010 Brian Orelli	Watch a 40% Decline Disappear The greatest thing going for Johnson & Johnson is its diversity in product offerings.
The Motley Fool March 10, 2009 Brian Orelli	So Much Potential, So Little Growth In its quest to become the Johnson & Johnson of China, this purveyor of traditional Chinese medicine has been growing through acquisitions, but has paid for them through dilutive stock offerings.
InternetNews February 22, 2008 Kenneth Corbin	Microsoft Talks Up Yahoo Integration Plans An internal Microsoft e-mail reads like a tool to pressure Yahoo to come to the table.
The Motley Fool July 20, 2010 Brian Orelli	Is J&J a Bad News Buy? Another quarter in 2010, another lowered earnings guidance for Johnson & Johnson. At least the year is half over for the health-care giant.
Bank Systems & Technology September 2, 2010 Katherine Burger	Paul Johnson of BB&T: Transformation Never Ends Nearing completion of a program to overhaul the way his technology organization operates and how it is viewed by the business, BB&T EVP and CIO Paul Johnson says the evolution of IT is an ongoing journey.
The Motley Fool July 12, 2011 Todd Wenning	What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors.
The Motley Fool January 26, 2010 Brian Orelli	Is the Best of Johnson & Johnson Behind It? Johnson & Johnson announces that its sales fell for the first time in 76 years.
Fast Company November 2015 Max Chafkin	How Failed JC Penney CEO Ron Johnson Is Redeeming Himself With Enjoy The company sells consumer electronics via the web and has its couriers, or "Experts," in Johnson's parlance, act as modern-day Maytag Men, hand-delivering the items in as little as four hours.
The Motley Fool January 18, 2012	What Johnson & Johnson Does With Its Cash Over the last five years, Johnson & Johnson shares returned 14%, which drops to -3% without dividends -- not a bad boost to top off otherwise lowly share performance.
The Motley Fool January 20, 2009 Brian Orelli	Johnson & Johnson Nimble ... for Now The health-care giant reports increasing earnings, despite falling revenue.
The Motley Fool June 15, 2011 Brian Orelli	Johnson & Johnson Is a Quitter The diversified health-care giant has decided to exit the drug-eluting stent market.
The Motley Fool February 26, 2007 Tim Beyers	Fool on the Street: Healthy Heinz Apparently, selling health is healthy for business. But organic innovation isn't the most important factor in going global. Investors, take note.
Bank Systems & Technology May 26, 2008 Lisa Valentine	EVP and CIO Paul Johnson Guides BB&T Corp. in Organic Growth Financial services giant BB&T is looking at organic growth to fuel its future success by transforming the firm's IT organization into a "value center" more akin to a line of business.
The Motley Fool November 9, 2006 Shruti Basavaraj	The Best Blue Chip for 2007: Johnson & Johnson If you're out looking for the best blue chip money can buy, consider Johnson & Johnson. The stock combines strong growth opportunities with stability. It's the ideal stock to build the core of your portfolio.
The Motley Fool July 9, 2010 Brian Orelli	Hey, Johnson & Johnson: Eight Is Enough If Johnson & Johnson can't overcome the negative image from recalls quickly, consumers will head to competing brand-name drugs or just grab generic versions of Johnson & Johnson's products.